DK0668290T3 - Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen - Google Patents

Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen

Info

Publication number
DK0668290T3
DK0668290T3 DK95105215T DK95105215T DK0668290T3 DK 0668290 T3 DK0668290 T3 DK 0668290T3 DK 95105215 T DK95105215 T DK 95105215T DK 95105215 T DK95105215 T DK 95105215T DK 0668290 T3 DK0668290 T3 DK 0668290T3
Authority
DK
Denmark
Prior art keywords
biomembrane
permeating
active substance
physiologically active
substance capable
Prior art date
Application number
DK95105215T
Other languages
English (en)
Inventor
Kouki Kitagawa
Toru Hibi
Noriko Mizobuchi
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Application granted granted Critical
Publication of DK0668290T3 publication Critical patent/DK0668290T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/2672-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • C07K14/702Enkephalins with at least 1 amino acid in D-form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
DK95105215T 1990-02-28 1991-02-27 Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen DK0668290T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5011690 1990-02-28

Publications (1)

Publication Number Publication Date
DK0668290T3 true DK0668290T3 (da) 1999-07-26

Family

ID=12850141

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91905340.5T DK0516851T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran
DK95105215T DK0668290T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91905340.5T DK0516851T3 (da) 1990-02-28 1991-02-27 Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran

Country Status (5)

Country Link
EP (2) EP0516851B1 (da)
CA (1) CA2076849A1 (da)
DE (2) DE69120397T2 (da)
DK (2) DK0516851T3 (da)
WO (1) WO1991013081A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264129B1 (it) * 1993-04-09 1996-09-16 Codev S A Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
US7880001B2 (en) 2004-04-29 2011-02-01 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
US8415354B2 (en) 2004-04-29 2013-04-09 Abbott Laboratories Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20100222316A1 (en) 2004-04-29 2010-09-02 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US8198331B2 (en) 2005-01-05 2012-06-12 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
EP2835367A1 (en) 2005-01-05 2015-02-11 AbbVie Inc. Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
US20090192198A1 (en) 2005-01-05 2009-07-30 Abbott Laboratories Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
NZ555966A (en) 2005-01-05 2011-03-31 Abbott Lab Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
JP5736098B2 (ja) 2007-08-21 2015-06-17 アッヴィ・インコーポレイテッド 中枢神経系障害を治療するための医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1179997A1 (ru) * 1973-02-28 1985-09-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср Средство дл лечени паркинсонизма "глудантан
JPS5143769A (en) * 1974-10-14 1976-04-14 Asahi Chemical Ind 11 beeta dd arabinofuranoshirushitoshinjudotaino seizoho
JPS5919557B2 (ja) * 1979-05-02 1984-05-07 ヤマサ醤油株式会社 N↑6−置換コルジセピン誘導体およびその製造法
US4273704A (en) * 1979-12-03 1981-06-16 G. D. Searle & Co. N-Adamantane-substituted tetrapeptide amides
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
NO170884C (no) * 1986-08-18 1992-12-23 Hoffmann La Roche Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
JPH0717655B2 (ja) * 1987-05-27 1995-03-01 三共株式会社 経口用セフアロスポリン化合物

Also Published As

Publication number Publication date
DE69130489T2 (de) 1999-05-12
DE69120397T2 (de) 1996-11-07
EP0668290B1 (en) 1998-11-11
WO1991013081A1 (fr) 1991-09-05
EP0516851A1 (en) 1992-12-09
EP0668290A1 (en) 1995-08-23
DE69120397D1 (de) 1996-07-25
CA2076849A1 (en) 1991-08-29
DE69130489D1 (de) 1998-12-17
DK0516851T3 (da) 1996-07-15
EP0516851A4 (en) 1993-06-09
EP0516851B1 (en) 1996-06-19

Similar Documents

Publication Publication Date Title
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
ATE98480T1 (de) Arzneimittelformulierungen.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
NO874873L (no) Anordning for autoadministrering av fysiologisk aktive stoffer, med forhindring av overdosering.
FI910851A0 (fi) 3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen.
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
FI891227A (fi) Katekolderivat och farmaceutiska preparat som innehaoller dessa.
DK0668290T3 (da) Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
MX9204635A (es) Procedimiento para la preparacion de derivados de beta-fenilisoserina.
FI890853A (fi) Farmaceutiskt preparat som tryggar transdermal absorption av den aktiva bestaondsdelen och foerfarande foer framstaellning daerav.
FI864164A0 (fi) Biologiskt aktiva derivat av human- -interferon, deras framstaellning och laekemedel, som innehaoller dylika derivat.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
DK166352C (da) Azolylmethylcyclopentanderivat, fremgangsmaade til fremstilling heraf samt landbrugsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel
NO910022D0 (no) Fungiside virkestoffkombinasjoner.
FI923371A0 (fi) En farmaceutisk formulation.
FI894072A (fi) Polypeptider anvaendbara som vaccin.
CL2004000486A1 (es) Compuestos de (piridinil amino)-bencisoxazol y bencisotiazol substituidos, la composicion farmaceutica que los contiene, su procedimiento de preparacion a partir de un bencisoxazol o bencisotiazol y su uso como farmaco con actividad antidepresiva.
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
MX9202987A (es) Analogos de insulina, formulacion farmaceutica que los contiene y procedimiento para obtener dichos analogos.
FI883738A0 (fi) Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret haemmande medel.
DE68908838D1 (de) Pharmazeutisch wirksame Dithioketen-Derivaten.
DK162631C (da) Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen
DK170491A (da) Oxo-ionolcarbonater anvendelige som tobaksaromastoffer